Total Credits: 1.0 including 1.0 AOA Category 1-A Credit(s), 1.0 AMA PRA Category 1 Credit(s)™
HIV management
Rachael Pellegrino, MD, MPH
Learning Objectives:
Dr. Pellegrino will discuss the use of 2-1-1 dosing of oral PrEP (emtricitabine/tenofovir disoproxil fumarate) for HIV is not FDA approved, but this method of PrEP dosing is included in the CDC PrEP guidelines is important to note. I have clearly identified in the slide that this is not FDA approved but is a part of the CDC PrEP guidelines.
Dr. Pellegrino has no financial disclosures.
Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
The AOMA designates this activity for a maximum of 1.0 hours of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AOMA designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOMA Grievance Policy: The Arizona Osteopathic Medical Association strives to provide continuing medical education programs that fulfill the needs of attendees and meet the requirements of AOA Accreditation and ACCME Accreditation. Comments, questions, or complaints should be submitted in writing to Teresa Roland, Director of Education, by mail to AOMA, 3039 W. Peoria Ave, Suite C102-158, Phoenix, AZ 85029, or email teresa@azosteo.org.
| HIV management (2.6 MB) | 29 Pages | Available after Purchase |
Rachael Pellegrino is an infectious disease physician and researcher. She is an Instructor in the Division of Infectious Diseases at Vanderbilt University Medical Center (VUMC). She received her MD and MPH from Johns Hopkins University and completed her Internal Medicine residency and Infectious Diseases' fellowship at VUMC. Her research investigates methods for optimizing the delivery of preventative care services in comprehensive HIV care. Her current projects include exploring the implementation of standardized practices for prescribing Doxycycline post-exposure prophylaxis to reduce sexually transmitted infections and methods for improving cancer prevention, screening, and patient-centered outcomes for people with HIV.